Evidence map›Paper›PMID 38328974›Full record

ReviewStroke2024

Evolution and Future of Stroke Trials.

Joseph P Broderick, Eva A Mistry

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Stroke, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Joseph P BroderickDepartment of Neurology and Rehabilitation Medicine, University of Cincinnati Gardner Neuroscience Institute, OH.
Eva A MistryDepartment of Neurology and Rehabilitation Medicine, University of Cincinnati Gardner Neuroscience Institute, OH.ORCID 0000-0002-7426-3650

Funding

NSTN National Clinical Coordinating CenterU01NS086872 · NINDS · UNIVERSITY OF CINCINNATI · PI Joseph Paul Broderick, Pooja Khatri · 2013 to 2026
$32.3M
Making Acute Stroke Trials Succeed: Challenges and Potential SolutionsU01NS110772 · NINDS · UNIVERSITY OF CINCINNATI · PI Joseph Paul Broderick, Jordan J. Elm · 2020 to 2026
$24.3M
Multi-arm Optimization of Stroke Thrombolysis (MOST) Stroke TrialU01NS100699 · NINDS · WASHINGTON UNIVERSITY · PI ADEOYE, OPEOLU M, BARRETO, ANDREW D · 2018 to 2021
$18.8M
Workshop to Identify Collaborative Project(s) for the NIH StrokeNet and the Japan NEtwork for Clinical Stroke Trials (NECST)U01NS087748 · NINDS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Catherine R. Dillon, Jordan J. Elm · 2014 to 2026
$14.1M
Strategy for Improving Stroke Treatment Response (SISTER) TrialUH3NS125023 · NINDS · YALE UNIVERSITY · PI ELM, JORDAN J., KHATRI, POOJA · 2024 to 2025
$8.3M
Strategy for Improving Stroke Treatment Response (SISTER) TrialUG3NS125023 · NINDS · UNIVERSITY OF CINCINNATI · PI ELM, JORDAN J., KHATRI, POOJA · 2023 to 2023
$5.1M
Ohio Valley Regional Coordinating Center for NINDS Stroke Trial NetworkU24NS107241 · NINDS · UNIVERSITY OF CINCINNATI · PI Stacie Demel, Eva Mistry · 2018 to 2026
$2.9M
NINDS NIH HHS U01 NS086872NINDS NIH HHS U01 NS087748NINDS NIH HHS U01 NS100699NINDS NIH HHS U01 NS110772NINDS NIH HHS U24 NS107241NINDS NIH HHS UG3 NS125023NINDS NIH HHS UH3 NS125023
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Clinical Trials as TopicStrokeHumansantihypertensive agentscerebral angiographyfibrinolytic agentshumansneuroimagingstroketherapy, intervention

Identifiers

PMID38328974
PMCPMC11196204

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.